These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 23816796)

  • 1. Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
    Kotagale NR; Paliwal NP; Aglawe MM; Umekar MJ; Taksande BG
    Peptides; 2013 Sep; 47():7-11. PubMed ID: 23816796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test.
    Redrobe JP; Dumont Y; Fournier A; Quirion R
    Neuropsychopharmacology; 2002 May; 26(5):615-24. PubMed ID: 11927186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats.
    Taksande BG; Kotagale NR; Gawande DY; Bharne AP; Chopde CT; Kokare DM
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):955-63. PubMed ID: 24461723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
    Goyal SN; Upadhya MA; Kokare DM; Bhisikar SM; Subhedar NK
    Brain Res; 2009 Apr; 1266():45-53. PubMed ID: 19254701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice.
    Desai SJ; Borkar CD; Nakhate KT; Subhedar NK; Kokare DM
    Neuroscience; 2014 Sep; 277():818-30. PubMed ID: 25106129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
    Ishida H; Shirayama Y; Iwata M; Katayama S; Yamamoto A; Kawahara R; Nakagome K
    Hippocampus; 2007; 17(4):271-80. PubMed ID: 17265460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt's test in rats.
    Goyal SN; Kokare DM; Chopde CT; Subhedar NK
    Pharmacol Biochem Behav; 2006 Oct; 85(2):369-77. PubMed ID: 17052748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety.
    Morales-Medina JC; Dumont Y; Benoit CE; Bastianetto S; Flores G; Fournier A; Quirion R
    Neuropharmacology; 2012 Jan; 62(1):200-8. PubMed ID: 21803058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
    Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
    Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine, 17-β estradiol or folic acid combined with intra-lateral septal infusions of neuropeptide Y produced antidepressant-like actions in ovariectomized rats forced to swim.
    Molina-Hernández M; Téllez-Alcántara NP
    Peptides; 2011 Dec; 32(12):2400-6. PubMed ID: 21971371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease.
    Rangani RJ; Upadhya MA; Nakhate KT; Kokare DM; Subhedar NK
    Peptides; 2012 Feb; 33(2):317-28. PubMed ID: 22266216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the involvement of neuropeptide Y in the antidepressant effect of imipramine in type 2 diabetes.
    Nakhate KT; Yedke SU; Bharne AP; Subhedar NK; Kokare DM
    Brain Res; 2016 Sep; 1646():1-11. PubMed ID: 27208493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates.
    Upadhya MA; Dandekar MP; Kokare DM; Singru PS; Subhedar NK
    Neuropeptides; 2009 Aug; 43(4):303-14. PubMed ID: 19556004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agmatine attenuates nicotine induced conditioned place preference in mice through modulation of neuropeptide Y system.
    Kotagale NR; Walke S; Shelkar GP; Kokare DM; Umekar MJ; Taksande BG
    Behav Brain Res; 2014 Apr; 262():118-24. PubMed ID: 24440829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression.
    Bjørnebekk A; Mathé AA; Brené S
    Hippocampus; 2010 Jul; 20(7):820-8. PubMed ID: 19623606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y.
    Taksande BG; Kotagale NR; Nakhate KT; Mali PD; Kokare DM; Hirani K; Subhedar NK; Chopde CT; Ugale RR
    Br J Pharmacol; 2011 Sep; 164(2b):704-18. PubMed ID: 21564088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S; Li DL; Simmons RM
    J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebroventricular injection of a neuropeptide Y-Y1 receptor agonist increases while BIBP3226, a Y1 antagonist, reduces the infarct volume following transient middle cerebral artery occlusion in rats.
    Chen SH; Cheung RT
    Neuroscience; 2003; 116(1):119-26. PubMed ID: 12535945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.